Bevacizumab Plays a double-edged role in Neoadjuvant Therapy for Non-metastatic Breast Cancer: A Systemic Review and Meta-Analysis

MLA

Xinjie Chen, et al. “Bevacizumab Plays a Double-Edged Role in Neoadjuvant Therapy for Non-Metastatic Breast Cancer: A Systemic Review and Meta-Analysis.” Journal of Cancer, vol. 12, Jan. 2021, pp. 2643–53. EBSCOhost, https://doi.org/10.7150/jca.53303.

APA

Xinjie Chen, Xiaomin Wang, Yu Gao, Yunfei Ma, Tingting Ma, Gan-Lin Zhang, & Bingxue Li. (2021). Bevacizumab Plays a double-edged role in Neoadjuvant Therapy for Non-metastatic Breast Cancer: A Systemic Review and Meta-Analysis. Journal of Cancer, 12, 2643–2653. https://doi.org/10.7150/jca.53303

Chicago

Xinjie Chen, Xiaomin Wang, Yu Gao, Yunfei Ma, Tingting Ma, Gan-Lin Zhang, and Bingxue Li. 2021. “Bevacizumab Plays a Double-Edged Role in Neoadjuvant Therapy for Non-Metastatic Breast Cancer: A Systemic Review and Meta-Analysis.” Journal of Cancer 12 (January): 2643–53. doi:10.7150/jca.53303.